Ligand Exchange Strategy for Delivery of Ruthenium Complex Unit to Biomolecules Based on Ruthenium–Olefin Specific Interactions
暂无分享,去创建一个
H. Yamaguchi | S. Hirota | T. Matsuo | Catur Jatmika | Kazumo Wakabayashi | Ryosei Tamaki | Naoki Akiyama | Ibuki Nakamura
[1] S. Grayson,et al. It is Better with Salt: Aqueous Ring-Opening Metathesis Polymerization at Neutral pH , 2020, Journal of the American Chemical Society.
[2] F. Arnold,et al. Engineering new catalytic activities in enzymes , 2020, Nature Catalysis.
[3] S. Hirota,et al. Regioselective chemical modification of cysteine residues on protein surfaces focusing on local environment around the conjugation site. , 2020, Bioconjugate chemistry.
[4] S. Hirota,et al. Recent developments on creation of artificial metalloenzymes , 2019, Tetrahedron Letters.
[5] T. Ward,et al. Artificial Metalloenzymes: Challenges and Opportunities , 2019, ACS central science.
[6] I. Hamachi,et al. Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide , 2018, Nature Communications.
[7] Nikolaus Krall,et al. Site-selective protein-modification chemistry for basic biology and drug development. , 2016, Nature chemistry.
[8] Gonçalo J L Bernardes,et al. Advances in chemical protein modification. , 2015, Chemical reviews.
[9] S. Hirota,et al. Excimer emission properties on pyrene-labeled protein surface: correlation between emission spectra, ring stacking modes, and flexibilities of pyrene probes. , 2015, Bioconjugate chemistry.
[10] S. Hirota,et al. Effect of Added Salt on Ring-Closing Metathesis Catalyzed by a Water-Soluble Hoveyda–Grubbs Type Complex To Form N-Containing Heterocycles in Aqueous Media , 2013 .
[11] S. Hirota,et al. Reversible switching of fluorophore property based on intrinsic conformational transition of adenylate kinase during its catalytic cycle. , 2013, Bioconjugate chemistry.
[12] S. Wölfl,et al. From Catalysts to Bioactive Organometallics: Do Grubbs Catalysts Trigger Biological Effects? , 2011, ChemMedChem.
[13] Carolyn R Bertozzi,et al. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. , 2009, Angewandte Chemie.
[14] A. Casini,et al. Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds. , 2008, Journal of medicinal chemistry.
[15] R. Grubbs,et al. Novel reactivity of ruthenium alkylidenes in protic solvents: degenerate alkylidene proton exchange. , 2001, Journal of the American Chemical Society.
[16] R. Grubbs,et al. The development of L2X2Ru=CHR olefin metathesis catalysts: an organometallic success story. , 2001, Accounts of chemical research.